Department of Radiation Oncology, The Second Affiliate Hospital of Soochow University, Suzhou, Jiangsu, China.
Department of Radiation Oncology, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Neoplasma. 2023 Apr;70(2):229-239. doi: 10.4149/neo_2023_220828N871. Epub 2023 Mar 24.
Wilms' tumor 1-associated protein (WTAP), a component of the m6A methyltransferase complex, recruits the m6A methyltransferases METTL3 and METTL14 to the corresponding mRNA targets to participate in the formation of N6-methyladenosine. However, the molecular mechanism of WTAP in the tumorigenesis and progression of nasopharyngeal carcinoma (NPC) remains unclear. This study aimed to explore the prognostic value and biological function of WTAP in NPC. We assessed WTAP expression and its prognostic significance using microarray datasets from the Gene Expression Omnibus (GSE12452) database and 100 NPC tissues via bioinformatics analysis and immunohistochemistry (IHC), respectively. Moreover, gene ontology (GO) and gene set enrichment analysis (GSEA) were performed. In addition, the correlation of WTAP expression with the expression of immune cell biomarkers was analyzed. The results showed that WTAP expression was significantly overexpressed in NPC tissues in GSE12452. The overexpression of WTAP was validated by the external datasets including NPC tissues (GSE150430) and NPC cell lines (GSE39826). GO analysis suggested enrichment in the nucleoplasm (cellular component) and cell cycle (biological process). The GSEA revealed that differentially expressed genes were enriched in E2F-targets, Myc_targets_v1, G2M checkpoint, Myc_targets_v2, and Interferon-alpha-response. In IHC analysis, WTAP was upregulated in NPC tissues, and high levels of WTAP expression were significantly correlated with the advanced T stage (p=0.047) and advanced N stage (p=0.018). Cox regression demonstrated that WTAP overexpression was an independent biomarker of poor prognosis for overall survival (hazard ratio [HR], 4.747; 95% confidence interval [CI], 1.671-13.482; p=0.003). In IHC analysis, the expression of WTAP was positively correlated with CD206 (biomarker for M2 macrophages) (p=0.018) but negatively correlated with CD8a (biomarker for cytotoxic T cells) (p=0.001). In conclusion, WTAP is a promising prognostic biomarker and may participate in the regulation of immune cell infiltration in NPC.
威尔姆斯瘤相关蛋白 (WTAP) 是 m6A 甲基转移酶复合物的组成部分,可招募 m6A 甲基转移酶 METTL3 和 METTL14 到相应的 mRNA 靶标上,参与 N6-甲基腺苷的形成。然而,WTAP 在鼻咽癌 (NPC) 发生和进展中的分子机制尚不清楚。本研究旨在探讨 WTAP 在 NPC 中的预后价值和生物学功能。我们通过生物信息学分析和免疫组织化学 (IHC) 分别使用来自基因表达综合数据库 (GEO) (GSE12452) 的微阵列数据集和 100 个 NPC 组织评估了 WTAP 表达及其预后意义。此外,还进行了基因本体论 (GO) 和基因集富集分析 (GSEA)。此外,分析了 WTAP 表达与免疫细胞生物标志物表达的相关性。结果表明,在 GSE12452 中 NPC 组织中 WTAP 表达明显上调。通过包括 NPC 组织 (GSE150430) 和 NPC 细胞系 (GSE39826) 的外部数据集验证了 WTAP 的过表达。GO 分析表明在核质 (细胞成分) 和细胞周期 (生物过程) 中富集。GSEA 表明差异表达基因在 E2F-靶标、Myc-靶标_v1、G2M 检查点、Myc-靶标_v2 和干扰素-α-反应中富集。在 IHC 分析中,WTAP 在 NPC 组织中上调,高水平的 WTAP 表达与晚期 T 分期 (p=0.047) 和晚期 N 分期 (p=0.018) 显著相关。Cox 回归表明,WTAP 过表达是总生存期不良预后的独立生物标志物 (危险比 [HR],4.747;95%置信区间 [CI],1.671-13.482;p=0.003)。在 IHC 分析中,WTAP 的表达与 CD206 (M2 巨噬细胞的标志物) (p=0.018) 呈正相关,与 CD8a (细胞毒性 T 细胞的标志物) (p=0.001) 呈负相关。总之,WTAP 是一种很有前途的预后生物标志物,可能参与 NPC 中免疫细胞浸润的调节。